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Abstract
Background—Genome-wide association studies (GWAS) for body mass index (BMI)
previously identified a locus near TMEM18. We conducted targeted sequencing of this region to
investigate the role of common, low frequency, and rare variation influencing BMI.
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Methods and Results—We sequenced TMEM18 and regions downstream of TMEM18 on
chromosome 2 in 3976 individuals of European ancestry from three community-based cohorts
(Atherosclerosis Risk in Communities, Cardiovascular Health Study and Framingham Heart
Study), including 200 adults selected for high BMI. We examined the association between BMI
and variants identified in the region from nucleotide position 586,432 to 677,539 (hg18). Rare
variants (MAF <1%) were analyzed using a burden test and the Sequence Kernel of Association
Test (SKAT). Results from the three cohort studies were meta-analyzed. We estimate that mean
BMI is 0.43 kg/m2 higher for each copy of the G allele of SNP rs7596758 (MAF=29%, p=3.46 ×
10−4) using a Bonferroni threshold of p <4.6 × 10−4). Analyses conditional on previous GWAS
SNPs associated with BMI in the region led to attenuation of this signal and uncovered another
independent (r2<0.2), statistically significant association, rs186019316 (p=2.11 × 10−4). Both
rs186019316 and rs7596758 or proxies are located in transcription factor binding regions. No
significant association with rare variants was found in either the exons of TMEM18 or the 3’
GWAS region.
Conclusions—Targeted sequencing around TMEM18 identified two novel BMI variants with
possible regulatory function.
Keywords
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Introduction
Body mass index (BMI), an important risk factor for diabetes mellitus and coronary heart
disease, is a complex trait with variation attributable to both environmental and genetic
factors. The heritability of BMI has been variously estimated between 25–75% overall,
indicating a substantial genetic influence1, and both common and rare variants have been
associated with BMI. Rare mutations have been identified in families with Mendelian forms
of obesity, where family members carrying these highly penetrant rare variants typically
demonstrate extreme obesity with early onset in childhood2–4. In the general population, the
Genetic Investigation of Anthropometric Traits (GIANT) consortium identified 32 common
variants through genome-wide association studies (GWAS), including loci FTO, TMEM18
and MC4R5, associated with BMI.
While the large sample sizes of GWAS have identified loci strongly associated with BMI,
together they explain less than 2% of the total variation in BMI5. The majority of variants
identified by GWAS are not obviously functional, and associated variants may simply serve
as markers for the underlying functional variants. This study evaluated the TMEM18 region
(~91kb) including the TMEM18 gene and downstream, using targeted deep resequencing.
Study goals were (1) to localize functional variants in this region and (2) to determine
whether low frequency and rare functional variants contribute additionally to the genetic
signal for BMI in this region. We chose this region for two reasons: first, it contains one of
the primary replicated genome-wide signals for BMI5, 6 and second, the GWA signal is
intergenic, downstream (3’) of the TMEM18 gene and therefore not covered by ongoing
exome sequencing efforts in these populations. In addition, FTO is a well-established locus
that has attracted the efforts of other groups such as Almen et al. (2013) 7. Considering the
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limited resources available for each Phenotype Group in the Cohorts for Heart and Aging
Research in Genomic Epidemiology (CHARGE)8 Targeted Sequencing study, we chose
TMEM18 and its downstream region to maximize our contribution and impact on the field.
We used data from the CHARGE Targeted Sequencing Study, which completed targeted
resequencing and analysis of 3976 individuals with BMI of European ancestry from three
community-based cohorts, Atherosclerosis Risk in Communities (ARIC), Cardiovascular
Health Study (CHS), and Framingham Heart Study (FHS).
Methods
Study Design and Samples
Briefly, the CHARGE Targeted Sequencing Study implemented a case-cohort study design,
in which both a random sample of participants (Cohort Random Sample) and participants
with extreme values on 14 traits (14 Phenotype Groups) were selected from each of the three
participating cohorts 9. The Phenotype Group for the BMI trait included participants from
each cohort who were selected as having the highest BMI levels for their sex and age, 100
from ARIC, 50 from CHS, and 50 from FHS. Our analysis included the 194 participants
selected on the basis of high BMI, 1862 participants in other Phenotype Groups, and 1920
participants from the Cohort Random Sample (Table 1). In total, we analyzed 3,974
individuals with available BMI measurements in the Cohort Random Sample and Phenotype
Groups (Table 1). To avoid confounding by race, all participants were of European ancestry.
In addition, all participants in this study provided informed consent for the use of their
genetic and other data to their local institutions. All studies were approved by institutional
review committee as well as the informed consent of subjects.
Sequence Data, QC, and Bioinformatics for Functional Annotation
We used targeted resequencing, covering the region from 586,432 bp to 677,539 bp (hg18),
and excluding regions with high GC content or which were highly conserved, for a total
sequencing of 71,457 bp. Sequences were custom captured by a NimbleGen Capture array
and sequenced using the ABI SOLiD V4.0 platform. Sequence read alignment (mapping)
was performed using the BFAST10 algorithm, based on the hg 18 reference genome (NCBI
Genome Build 36). SAMtools11 was used to convert the aligned read information into pileup
data. The pileup results were filtered producing variant calls and annotated using the
ANNOVAR12 software package. Details are fully provided in a separate manuscript 9.
Information for the resequenced region from dbSNP build 135 was retrieved from the NCBI
ftp site13, 14. Functional annotations from dbSNP were parsed and RsMergeArch was used
to create mappings of all alias SNP identifiers. Regulatory variants were assessed using the
current hg19 version of transcription factor binding sites from the ENCODE project, with
positions translated to hg1815. These were determined by experiments using chromatin
immunoprecipitation combined with next-generation sequencing (ChIP-seq) technologies.
Reported variants were confirmed using regulatory information from the HaploReg
database16.
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Details of the statistical approach are available 9.
Single Variant Analysis—We defined common variants as SNPs with at least 50
individuals carrying one or more minor alleles among all participants sequenced; this was
approximately equal to 1% allele frequency. For each common variant, we conducted an
association analysis, using linear regression for ARIC and CHS samples and a linear mixed
effects model for related FHS samples, with BMI as the dependent variable, each single
variant as the primary independent variable, and adjustment for sex, age, age-squared, study
center and principal components, as appropriate, to account for possible population
stratification. Principal components were calculated using genome-wide genotype data
within each cohort. We performed unweighted regression analyses to obtain p-values for
associations and weighted regression analyses to obtain effect estimates that accounted for
the sampling design (Lumley T, Dupuis J, Rice KM, Barbalic M, Bis JC, Cupples LA, et al.
http://stattech.wordpress.fos.auckland.ac.nz/files/2012/05/design-paper.pdf). We applied a
Bonferroni-corrected threshold to determine statistical significance of association for
common variants, defined as 0.05 divided by the effective number of independent SNPs in
the targeted region17: 4.6x10−4 =0.05/108, where the effective number of independent SNPs
out of 288 common variants is calculated based on the eigenvalues of the genetics
correlation matrix proposed by Li and Ji17.
We performed two conditional analyses: each added one of the two regional SNPs
(rs6548238 and rs2867125) previously identified by GIANT GWAS into the regression
model as a covariate and tested all remaining regional SNPs for association. The
interrogated region, near the TMEM18 gene, was first identified by the GIANT consortium
in 20096 and the lead SNP, rs6548238, is located 3’ of the gene at 624,905 bp (hg18), a
region that contains no other genes. This finding was later confirmed by analysis of data
from a larger group of studies in GIANT5 with a different lead SNP, rs2867125 at 612827bp
(hg18), which is in complete linkage disequilibrium with the SNP from the original report
according to the HapMap CEU 1000G Pilot 1 data (r2 and D’ = 1). Additionally, we
conditioned on a SNP identified in the unconditional analyses of these data and tested all
remaining SNPs in the region.
Rare Variant Analysis—For variants with minor allele frequency less than 1%, we
conducted analyses that collapsed or jointly modeled rare variants within our genomic
region. Multiple variant tests have lower power to detect association when they include non-
functional variants18, 19. Hence, we conducted rare variant analyses in three ways: the first
included all rare SNPs, the second included all ten rare non-synonymous or splice-site SNPs
within TMEM18 exons, and the third included all 370 SNPs in the region located in
transcription factor binding sites according to ENCODE criteria20. We used a T1 count test
by analyzing the association of an aggregated statistic (the number of variants with at least
one minor allele present). In addition, we conduct a Sequence Kernel Association Test
(SKAT) to detect associations from variants with possibly different directions of effect.
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Meta-Analysis—For single-variant analysis of common SNPs and T1 analysis of rare
SNPs, we performed fixed-effects, inverse-variance weighted meta-analysis of study-
specific association results to combine the association evidence across studies. For SKAT,
we combined score and information components of the study-specific statistics to compute a
combined SKAT statistic that adjusted for study 9.
Results
We analyzed a total of 2,180 variants, including 1,629 novel variants not found in the 1000
Genomes Project, in or near TMEM18 with minor allele frequencies ranging from 0.0002 to
0.49. (Figure 1) A total of 288 variants were considered to be common. The vast majority of
the variants were intergenic. Of the 2180 investigated variants, 405 (35 common) were
located in transcription factor binding regions assayed by ChIP-seq. In the subset of 288
common variants, there were 43 independent (r2<0.2) and nominally significant (p<0.05)
SNPs associated to BMI, 8 of them in regulatory regions (Supplementary Table 1).
Single Variant Results
The SNPs previously reported by GIANT GWAS to be associated with BMI5, 6, rs6548238
and rs2867125, displayed nominally significant (p = 0.007 and 0.039, respectively)
associations with BMI in our data (Table 2 and Figure 2). Our samples in this study are
subsets of GIANT GWAS and our results for these variants are consistent with those of
GIANT, with the same direction of effect (C allele of each variant increasing BMI) and a
greater magnitude of effect in our data (0.46 vs. 0.26 for rs6548238 and 0.41 vs. 0.31 in
GIANT for rs2867125)5, 6. Allele frequencies for these variants (18%) are similar in our
data to those of GIANT (17% and 16%).
We identified another significantly associated variant in this region – rs7596758 (MAF =
28.8%, p = 3.46E-4) (Table 2, Figure 2) in a cluster of several variants all showing
association. For each additional G allele of this variant, we estimate that mean BMI is higher
by 0.43 kg/m2. While this variant is in perfect linkage disequilibrium with both GIANT
GWAS SNPs (D’=1), it is not correlated (r2=0.08), according to 1000G Pilot 1.
Conditioning on our top SNP, rs7596758, substantially weakened the estimated effect sizes
of the GIANT GWAS signals (Table 3) from a magnitude greater than 0.4 to less than 0.1.
In contrast, conditioning on either GIANT signal only modestly lowered the effect size of
our top signal rs7596758 from 0.43 to ~0.30. Analysis conditional on rs2867125 also
identified an additional significant variant rs186019316 (p-value < 4.6E-4, MAF=2.2%),
which is only weakly correlated with the GWAS SNPs and our top hit, rs7596758 (r2 < 0.01
in ARIC data).
None of the 287 additional common or low frequency variants within the TMEM18 region,
including coding or functional variants in TMEM18, were significantly associated with BMI.
Analysis of Rare Variants
The results from T1 count tests summarizing all rare SNPs and SKAT-based joint
association of all rare SNPs for the TMEM18 region provide no support for an association
between rare variants in the region and BMI (p = 0.56 for T1; p=0.44 for SKAT). We also
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performed T1 and SKAT tests restricting to the 10 exonic functional (nonsynonymous or
splice-site) variants or the 370 SNPs localized within transcription factor binding sites in the
TMEM18 region; none of these associations were statistically significant (10 exonic SNPs:
p=0.50 for T1, p=0.85 for SKAT and 370 transcription factor binding sites: p=0.97 for T1;
p=0.72 for SKAT).
Discussion
This study aimed to fine map the previously identified GWAS signal near TMEM18 and to
identify any independent variant(s) in the region using the targeted resequencing data. We
found a cluster of associated SNPs, one of which, rs7596758, exceeded a Bonferroni-
corrected statistical significance threshold of 4.6 × 10 −4. Further analyses conditioning on
the previously reported associated SNPs in the region from GWAS identified another low-
frequency variant, rs186019316. Both variants lie in transcription factor binding regions.
One possible limitation of our findings is the observed heterogeneity across the cohort
samples and attenuated evidence of association in a random effects meta-analysis
(Supplementary Table 2). Age differences between the three participating cohorts may have
potentially influenced our results. In support of this hypothesis, a growing literature has
demonstrated age specific differences in the magnitude of genetic associations 21–25. For
example, TMEM18 was reported to have larger BMI effect estimate in adolescents compared
with adults23. On average, the participants in the CHS study (mean age of 72.5 in yrs) are
older than the two studies (FHS: 37.0 and ARIC: 54.9) and displayed smaller genetic effect
sizes.
Advances in genotyping technology and the development of novel, powerful analytical
approaches have improved the accuracy and cost-effectiveness of testing variation in large
samples, and these facilitated the present study. Here, we detected and verified genetic
associations with BMI in a non-exonic region downstream of TMEM18, and extended our
investigation to include low frequency variants not represented in typical genome-wide
association studies of common haplotypes. This study relies on measurement of low-
frequency variants using genetic resequencing. Studies that impute genotypes cannot readily
examine low-frequency variant – disease associations, because imputation accuracy tends to
be low for rarer variants. Further, while many genetic association studies now concentrate
on exonic variation, few focus on association in non-coding regions. Along with the
significant progress made following up the 9p21 locus association with myocardial
infarction and coronary artery calcification, our study’s dual focus on non-coding variation
and sequence variation in the region in and near TMEM18 proved fruitful.
Both newly discovered variants, rs7596758 and rs186019316, reside within regions that
show evidence for transcription factor binding in ENCODE’s ChIP-seq results. SNP
rs17042288, a proxy for rs7596758 (r2=1, D’=1 in 1000G Pilot 1) with nominally significant
results, is in a region annotated for FOXA1 binding. The FOXA (or HNF3) protein family
may have a pivotal role in the regulation of metabolism26. FOXA1 has been shown to play
an important role in glucose homeostatis27 and glucose-stimulated insulin secretion28. SNP
rs186019316 lies in a putative binding region for REST, which represses transcription of
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neuron-specific genes by binding the neuron-restrictive silencer element (NRSE) and
restricting gene expression29, 30, but has not been reported to be related to adiposity biology.
However, using Genomatix (Genomatix, Munich, Germany) to query predicted transcription
factor binding motif alterations by these variants, we found no evidence that these variants
alter the canonical binding motifs for FOXA1 or REST. The functional role of the reported
SNPs needs to be further explored using in vitro experiments.
We demonstrate that for BMI, a complex quantitative trait, common variants downstream of
TMEM18 may influence trait variation. Although these associations need to be confirmed,
our findings add to the growing literature suggesting that GWAS signals tag regions where
multiple single-variants may be independently associated with the trait of interest31, 32.
These may span the spectrum from low-frequency to common variants, and increase the
total variance of the trait that is explained by genetic variation. Indeed, the variants we found
associated with BMI in the TMEM18 region differed with respect to their functional
significance, effect size, and allele frequency.
This study has several notable strengths. It represents the first attempt to fine-map the BMI
associated region near TMEM18 using a comprehensive resequencing approach in a large
sample of subjects. Second, TMEM18 represents a region repeatedly shown to be associated
with BMI5, 6, 23, 24 (cite a few sources, not just Giant. However, while our sample of nearly
4000 is large for current sequencing studies, even it is insufficient to detect small effects or
individual associations with rare or low frequency variants. Specifically, with a total sample
size of 3976, we have power of 51.38% to detect an effect size of 2.247, which is 0.1% of
the variation in BMI, for a variant with MAF of 1%. Finally, although replication of our
results would be desirable, because our focal region is not exonic, we know of no other
studies with sequence data available for replication. Despite these limitations, our study does
provide evidence for a possible regulatory role of this region with respect to adiposity.
In summary, our targeted resequencing study of the TMEM18 region of chromosome 2
reveals two variants associated with BMI, one of low frequency (2%) and the other common
(29%). Our results indicate that conditioning on SNP rs7596758 (MAF 29%) substantially
weakens the estimated effects of variants previously identified by GIANT. Further, our data
provide no evidence that TMEM18 coding variants influence the phenotype. Instead, the
data support a role for a region 3’ of the gene with annotated function that is likely to be
regulatory. Expanded studies will be needed to characterize this region and its effects
definitively.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Description of Variants Found in TMEM18 Region. There are 2180 variants (288 common
variants) in total found in chr2:586432-677539 region. The classification of these variants
includes 1891 variants annotated as intergenic, 164 intronic, 33 upstream, 25 downstream,
46 UTR3, 5 UTR5, 9 exonic nonsynonymous, 6 exonic synonymous, and 1 splicing. The
figure shows the percent of variants within each category stratified by the allele frequency
(rare/common variant). In addition, among 2180 variants, 405 (35 common) are in the
transcriptional region.
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Regional Association Plot for the Single Variant Analysis. The most significant variant
rs7596758 among a cluster of variants which are more significant than the GIANT Hit
(rs6548238 and rs2867125 with nominally significant p<0.05) is significant after adjusting
for multiple testing. SNP rs186019316 is not significant with p = 4.94E-4 in the single
variant analysis but is significant in the analysis conditioning on rs6548238 and rs2867125,
respectively.
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